Skip to main navigation
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Contact
  • Programs
    • HBV
    • Pipeline
  • Patients
    • Commitment
    • Clinical Trials
    • Resources
  • Sustainability
    • Overview
    • Business Ethics
    • Access to Health Care
    • Human Capital
    • Environment, Health and Safety
  • Collaborations
  • Investors
    • Press Releases
    • Events & Presentations
    • Corporate Governance
    • Financials & Filings
    • Stock Information
  • Careers
    • Culture
    • Benefits
    • Opportunities
On the
  • Press Releases
  • Events & Presentations

Event Details

AASLD – The Liver Meeting

Nov 12 - Nov 15, 2021

Supporting Materials

Poster – ABI-H3733 – Phase 1a 292.5 KB
Late-Breaker Poster – ABI-4334 – Preclinical characterization 452.6 KB
VBR – Despite continued treatment with NrtI, HBV pgRNA and DNA rebound following discontinuation of VBR 640.9 KB
Shareholder Tools Print Email Alerts Printed Materials RSS News Feeds
Search Investors

Contact Us

833.509.4583
info@assemblybio.com
LinkedIn
About Programs Patients Collaborations Investors Careers

© 2023 Assembly Biosciences, Inc.